Gastric bypass surgery is associated with reduced subclinical myocardial injury and greater activation of the cardiac natriuretic peptide system than lifestyle intervention

• Published in: Clinical biochemistry Vol. 86; pp. 36 - 44
• Main Authors: Aakre, Kristin M., Omland, Torbjørn, Nordstrand, Njord, Gjevestad, Espen S., Holven, Kirsten B., Lyngbakken, Magnus N., Hjelmesæth, Jøran
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2020
• Subjects: Adult; C-Reactive Protein - metabolism; Cardiovascular risk; CRP; Diet, Reducing; Exercise; Female; Gastric Bypass; Health Education; Heart Injuries - complications; Humans; Life Style; Male; Middle Aged; Myocarditis - complications; Natriuretic Peptides - blood; NT-proBNP; Obesity, Morbid - complications; Obesity, Morbid - diet therapy; Obesity, Morbid - surgery; Roux-en-Y gastric bypass; Troponin; Troponin I - blood; Troponin T - blood; Weight Loss; CRP; Troponin; NT-proBNP; Roux-en-Y gastric bypass; Weight loss; Cardiovascular risk
• ISSN: 0009-9120; 1873-2933
• DOI: 10.1016/j.clinbiochem.2020.09.006

Morbid obesity is a risk factor for cardiovascular disease. The relative effects of Roux-en-Y gastric bypass surgery (GBS) and intensive lifestyle intervention (ILI) on subclinical myocardial injury, the activity of the cardiac natriuretic system, and systemic inflammation remain unclear. In a 59-week non-randomized clinical trial that included 131 patients with morbid obesity, we compared the effects ofGBS and ILI on concentrations of cardiac troponin T (cTnT) and I (cTnI), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and C-reactive protein (CRP). In the GBS and ILI group, median body mass index (BMI) was reduced by 14.4 kg/m2 versus 3.9 kg/m2, respectively (p value < 0.001). Cardiac troponins decreased after GBS, p = 0.014 (cTnT) and p = 0.065 (cTnI) and increased significantly in those treated with ILI (p values ≤ 0.021) (between-group differences for deltas: p ≤ 0.003). NT-proBNP increased in both groups, but significantly more in the GBS than in the ILI group (between-group differences for deltas: p = 0.008). CRP decreased significantly within the GBS and the ILI group, with this change significantly greater in the GBS group (between-group differences for deltas p < 0.001). The dominating mediator of the biomarker changes was weight loss. Prior coronary artery disease and diabetes were predictive of the magnitude of the changes in cTnI and NT-proBNP, respectively. Compared to ILI, GBS was associated with reduced subclinical myocardial injury and systemic inflammation, and enhancement of the cardiac natriuretic peptide system. The biomarker changes were predominantly mediated by weight loss.